The FDA sent an early safety alert warning clinicians of deployment failures with certain Boston Scientific AXIOS Stent and ...
(HealthDay News) – The AXIOS Stent and Delivery System has been approved by the U.S. Food and Drug Administration to treat pancreatic pseudocysts, the FDA said in a news release. The AXIOS stent is a ...
Xlumena, Inc., a leader in the development of advanced endoscopic devices, today announced the close of a $25 million Series C financing. Led by Third Point LLC, the round of funding includes existing ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Boston Scientific is conducting a ...
Marlborough-based medical device manufacturer Boston Scientific has reached an agreement to acquire Xlumena Inc. Based in Mountain View, Calif., Xlumena makes minimally invasive devices to drain ...
The Axios Stent and Delivery System has been approved by the U.S. Food and Drug Administration to treat infected pancreatic cysts that won't drain on their own and could become life threatening, the ...
In the last month of 2015, the FDA granted 510(k) clearance to five gastroenterology and endoscopy devices. AXIOS Stent with Delivery System, AXIOS Stent with Electro-cautery Enhanced Delivery System ...